Journal article icon

Journal article

Advances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer

Abstract:

Introduction: The successful treatment of metastatic cancer is refractory to strategies employed to treat confined, primary lesions, such as surgical resection and radiation therapy, and thus must be addressed by systemic delivery of anti-cancer agents. Conventional systemically administered chemotherapeutics are often ineffective and come with severe dose-limiting toxicities. Areas covered: This review focuses on the recent developments in systemic therapy for metastatic cancer. Firstly, the...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Engineering Science
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Engineering Science
Role:
Author
Publisher:
Taylor and Francis
Journal:
Expert Opinion on Drug Delivery More from this journal
Volume:
13
Issue:
7
Pages:
999-1013
Publication date:
2016-04-15
Acceptance date:
2016-03-14
DOI:
EISSN:
1744-7593
ISSN:
1742-5247
Keywords:
Pubs id:
pubs:618436
UUID:
uuid:aabbaf67-8334-47ce-aeff-66100397cafc
Local pid:
pubs:618436
Source identifiers:
618436
Deposit date:
2016-06-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP